REN Jian-xun, FAN Xiao-di, LIU Jian-xun. Intervention Effect of Shuangshen Xionglian Granule on Atherosclerotic Inflammation in ApoE Mouse[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(24): 106-111.
DOI:
REN Jian-xun, FAN Xiao-di, LIU Jian-xun. Intervention Effect of Shuangshen Xionglian Granule on Atherosclerotic Inflammation in ApoE Mouse[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(24): 106-111. DOI: 10.13422/j.cnki.syfjx.2017240106.
Intervention Effect of Shuangshen Xionglian Granule on Atherosclerotic Inflammation in ApoE Mouse
Objective: To investigate the effects of Shuangshen Xionglian (SSXL) granule on atherosclerotic inflammation in ApoE-/- mice with high-fat diet. Method: C57BL/6 mice were used as normal control group (BLA). ApoE-/- mice were randomly divided into 4 groups:model group with atherosclerosis (MOD)
probucol treatment group (PRO
216 mg·kg-1)
SSXL high dose group (SSXL-H
1.6 g·kg-1) and SSXL low dose group (SSXL-L
0.8 g·kg-1). After 2 weeks of high-fat diet
blood lipids were measured by biochemical method and ApoE-/- mice were treated with different drugs. Blood lipids were measured again after 8-week treatment. Aortic intima thicknesses in ApoE-/- mice were analyzed by ultrasonic methods. Aortic plaque areas were observed by oil red O staining and ratio of plaque area/intravascular area was calculated. The expression levels of tumor necrosis factor (TNF)-α
interleukin (IL)-1α
IL-10 and monocyte chemoattractant protein (MCP)-1 in serum were detected by flow type high throughput multi-factor detection technique. Result: SSXL granule could decrease aortic intima thicknesses in ApoE-/- mice
reduce ratio of plaque area/intravascular area
inhibit the expression of TNF-α and MCP-1
but with no significant effects on changes of blood lipids. Conclusion: SSXL granule had obvious anti-atherosclerotic effect by suppressing inflammation but not depending on blood lipids level.
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Related Author
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
SHEN Tao
ZHANG Yong
LIANG Yuqin
Related Institution
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine